Related Experiment Video
Updated: Apr 28, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Giant cell arteritis: the internist should not be a lone rider in this potentially blinding condition
Insights
Giant cell arteritis can cause irreversible vision loss. Early diagnosis and active ophthalmologist involvement in managing corticosteroid treatment are crucial to prevent bilateral blindness.
Area of Science:
- Ophthalmology
- Rheumatology
- Internal Medicine
Background:
- Giant cell arteritis (GCA) is a systemic vasculitis often affecting older adults.
- Anterior ischemic optic neuropathy (AION) is a leading cause of sudden, painless vision loss in the elderly.
- GCA is a critical, treatable cause of AION that requires prompt management.
Observation:
- A 66-year-old woman presented with visual loss secondary to AION.
- Clinical and hematological findings supported the diagnosis of GCA.
- Despite initial corticosteroid therapy, the contralateral eye became involved, leading to permanent bilateral vision loss.
Findings:
- The patient experienced two relapses of GCA within six months of the initial episode.
- Corticosteroid treatment, while initiated, did not prevent disease progression or contralateral eye involvement.
- The case highlights the potential for GCA to cause severe, bilateral vision loss despite treatment.
Implications:
- Ophthalmologists must be highly familiar with the clinical presentation and diagnostic criteria for GCA.
- Active participation of ophthalmologists in the management, including corticosteroid tapering, is essential.
- Multidisciplinary collaboration is vital to prevent irreversible blindness in patients with GCA.
Abstract:
We report the case of a 66-year-old woman with visual loss due to anterior ischaemic optic neuropathy. The diagnosis of giant cell arteritis was made on the basis of classic clinical characteristics and haematological abnormalities. Despite corticosteroid treatment, involvement of the other eye occured, resulting in a bilateral and permanent loss of vision. The follow-up was marked by two relapses within the 6 months after the first episode. In order to prevent blindness, ophthalmologists should be familiar with this disorder and should actively participate in the treatment, not leaving the internist deciding alone about tapering corticotherapy.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Chronic Inflammation: Introduction
Rheumatic Heart Disease I: Introduction
Hypersensitivity Reactions: Immune-Complex Reactions
Myasthenia Gravis ll: Pathophysiology
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...

